cgp 35348 has been researched along with haloperidol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waldmeier, PC | 1 |
1 other study(ies) available for cgp 35348 and haloperidol
| Article | Year |
|---|---|
The GABAB antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis.
Topics: 4-Butyrolactone; Animals; Baclofen; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; GABA-A Receptor Antagonists; Haloperidol; Organophosphorus Compounds; Pyrrolidinones; Rats; Tetrabenazine | 1991 |